Cargando…
345. Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico
BACKGROUND: A large number of viral infections are characterized by the presence of cutaneous manifestations. Multiple dermatological manifestations have been observed in patients with COVID-19. Dermatological lesions in patients infected by SARS-CoV-2 such as livedo reticularis, rash and vascular l...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644377/ http://dx.doi.org/10.1093/ofid/ofab466.546 |
_version_ | 1784610071420862464 |
---|---|
author | Del Carpio-Orantes, Luis García-Méndez, Sergio Sánchez-Díaz, Jesús Salvador aguilar-silva, Andrés Aparicio-Sánchez, Elisa Estefania Cruz-Albarrán, Sonia Denis-Bravo, Jorge Luis Esparza-Mora, Iván Samantha González-Medel, Karem Hernández-Zaleta, Nelyda Verania López-Cruz, Edgar Alberto Montano-Montiel, Laura Guadalupe Morgado-Hernández, Jennifer Ivonne Muñoz-Aguilar, José Alberto Priego-Parra, Edson Irving Reich-Sierra, Reynaldo Sánchez-Jiménez, Noel Jhosimar Tress-Uc, María Fernanda Velázquez-Orozco, Paola |
author_facet | Del Carpio-Orantes, Luis García-Méndez, Sergio Sánchez-Díaz, Jesús Salvador aguilar-silva, Andrés Aparicio-Sánchez, Elisa Estefania Cruz-Albarrán, Sonia Denis-Bravo, Jorge Luis Esparza-Mora, Iván Samantha González-Medel, Karem Hernández-Zaleta, Nelyda Verania López-Cruz, Edgar Alberto Montano-Montiel, Laura Guadalupe Morgado-Hernández, Jennifer Ivonne Muñoz-Aguilar, José Alberto Priego-Parra, Edson Irving Reich-Sierra, Reynaldo Sánchez-Jiménez, Noel Jhosimar Tress-Uc, María Fernanda Velázquez-Orozco, Paola |
author_sort | Del Carpio-Orantes, Luis |
collection | PubMed |
description | BACKGROUND: A large number of viral infections are characterized by the presence of cutaneous manifestations. Multiple dermatological manifestations have been observed in patients with COVID-19. Dermatological lesions in patients infected by SARS-CoV-2 such as livedo reticularis, rash and vascular lesions may represent manifestations of secondary phenomena such as paraviral rashes or by participation of the innate or adaptive immune system that cause vasodilation, vascular leakage or procoagulant effects METHODS: Descriptive and observational study, adult patients with COVID-19 pneumonia were selected, confirmed by RT-PCR and chest CT. General symptoms, hematic cytometry results, pneumonia severity, prognosis as well as dermatological manifestations are characterized. RESULTS: 100 patients were entered into the study, with an average age of 49.4 years, 54% male. The general symptoms with the highest incidence were: fever, cough and dyspnea characteristic of SARS-CoV-2 infection, followed by chest pain, headache, anosmia and dysgeusia. The main alteration of the hemogram was lymphopenia, no leukopenia or plaquetopenia was demonstrated. 54% of those affected had mild pneumonia, the rest severe pneumonia. 75% progressed towards improvement and 25% died. Among the dermatological manifestations identified, all occurred in cases with severe pneumonia, the one with the highest incidence was the morbilliform viral exanthema in 18%, the presence of diffuse partial alopecia in 7% as well as manifestations of lividity and maceration in 1%. Regarding alopecia, in 6% it was reversible androgenetic alopecia, having manifested during the acute stage of pneumonia (all men), in 1% it presented alopecia areata (male) that has been persistent beyond the acute phase and in frank recovery Demographic and clinical variables [Image: see text] Clinical manifestations [Image: see text] CONCLUSION: The incidence of dermatological manifestations is low in this study population, the most frequent being the morbilliform viral exanthema expected in a virus, however they present manifestations of low incidence such as reversible androgenetic alopecia associated with severity of the disease, a finding that has been documented recently as a manifestation associated with COVID-19 DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-8644377 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-86443772021-12-06 345. Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico Del Carpio-Orantes, Luis García-Méndez, Sergio Sánchez-Díaz, Jesús Salvador aguilar-silva, Andrés Aparicio-Sánchez, Elisa Estefania Cruz-Albarrán, Sonia Denis-Bravo, Jorge Luis Esparza-Mora, Iván Samantha González-Medel, Karem Hernández-Zaleta, Nelyda Verania López-Cruz, Edgar Alberto Montano-Montiel, Laura Guadalupe Morgado-Hernández, Jennifer Ivonne Muñoz-Aguilar, José Alberto Priego-Parra, Edson Irving Reich-Sierra, Reynaldo Sánchez-Jiménez, Noel Jhosimar Tress-Uc, María Fernanda Velázquez-Orozco, Paola Open Forum Infect Dis Poster Abstracts BACKGROUND: A large number of viral infections are characterized by the presence of cutaneous manifestations. Multiple dermatological manifestations have been observed in patients with COVID-19. Dermatological lesions in patients infected by SARS-CoV-2 such as livedo reticularis, rash and vascular lesions may represent manifestations of secondary phenomena such as paraviral rashes or by participation of the innate or adaptive immune system that cause vasodilation, vascular leakage or procoagulant effects METHODS: Descriptive and observational study, adult patients with COVID-19 pneumonia were selected, confirmed by RT-PCR and chest CT. General symptoms, hematic cytometry results, pneumonia severity, prognosis as well as dermatological manifestations are characterized. RESULTS: 100 patients were entered into the study, with an average age of 49.4 years, 54% male. The general symptoms with the highest incidence were: fever, cough and dyspnea characteristic of SARS-CoV-2 infection, followed by chest pain, headache, anosmia and dysgeusia. The main alteration of the hemogram was lymphopenia, no leukopenia or plaquetopenia was demonstrated. 54% of those affected had mild pneumonia, the rest severe pneumonia. 75% progressed towards improvement and 25% died. Among the dermatological manifestations identified, all occurred in cases with severe pneumonia, the one with the highest incidence was the morbilliform viral exanthema in 18%, the presence of diffuse partial alopecia in 7% as well as manifestations of lividity and maceration in 1%. Regarding alopecia, in 6% it was reversible androgenetic alopecia, having manifested during the acute stage of pneumonia (all men), in 1% it presented alopecia areata (male) that has been persistent beyond the acute phase and in frank recovery Demographic and clinical variables [Image: see text] Clinical manifestations [Image: see text] CONCLUSION: The incidence of dermatological manifestations is low in this study population, the most frequent being the morbilliform viral exanthema expected in a virus, however they present manifestations of low incidence such as reversible androgenetic alopecia associated with severity of the disease, a finding that has been documented recently as a manifestation associated with COVID-19 DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2021-12-04 /pmc/articles/PMC8644377/ http://dx.doi.org/10.1093/ofid/ofab466.546 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster Abstracts Del Carpio-Orantes, Luis García-Méndez, Sergio Sánchez-Díaz, Jesús Salvador aguilar-silva, Andrés Aparicio-Sánchez, Elisa Estefania Cruz-Albarrán, Sonia Denis-Bravo, Jorge Luis Esparza-Mora, Iván Samantha González-Medel, Karem Hernández-Zaleta, Nelyda Verania López-Cruz, Edgar Alberto Montano-Montiel, Laura Guadalupe Morgado-Hernández, Jennifer Ivonne Muñoz-Aguilar, José Alberto Priego-Parra, Edson Irving Reich-Sierra, Reynaldo Sánchez-Jiménez, Noel Jhosimar Tress-Uc, María Fernanda Velázquez-Orozco, Paola 345. Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico |
title | 345. Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico |
title_full | 345. Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico |
title_fullStr | 345. Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico |
title_full_unstemmed | 345. Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico |
title_short | 345. Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico |
title_sort | 345. dermatological manifestations in patients with covid-19 pneumonia in veracruz, mexico |
topic | Poster Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644377/ http://dx.doi.org/10.1093/ofid/ofab466.546 |
work_keys_str_mv | AT delcarpioorantesluis 345dermatologicalmanifestationsinpatientswithcovid19pneumoniainveracruzmexico AT garciamendezsergio 345dermatologicalmanifestationsinpatientswithcovid19pneumoniainveracruzmexico AT sanchezdiazjesussalvador 345dermatologicalmanifestationsinpatientswithcovid19pneumoniainveracruzmexico AT aguilarsilvaandres 345dermatologicalmanifestationsinpatientswithcovid19pneumoniainveracruzmexico AT apariciosanchezelisaestefania 345dermatologicalmanifestationsinpatientswithcovid19pneumoniainveracruzmexico AT cruzalbarransonia 345dermatologicalmanifestationsinpatientswithcovid19pneumoniainveracruzmexico AT denisbravojorgeluis 345dermatologicalmanifestationsinpatientswithcovid19pneumoniainveracruzmexico AT esparzamoraivan 345dermatologicalmanifestationsinpatientswithcovid19pneumoniainveracruzmexico AT samanthagonzalezmedelkarem 345dermatologicalmanifestationsinpatientswithcovid19pneumoniainveracruzmexico AT hernandezzaletanelydaverania 345dermatologicalmanifestationsinpatientswithcovid19pneumoniainveracruzmexico AT lopezcruzedgaralberto 345dermatologicalmanifestationsinpatientswithcovid19pneumoniainveracruzmexico AT montanomontiellauraguadalupe 345dermatologicalmanifestationsinpatientswithcovid19pneumoniainveracruzmexico AT morgadohernandezjenniferivonne 345dermatologicalmanifestationsinpatientswithcovid19pneumoniainveracruzmexico AT munozaguilarjosealberto 345dermatologicalmanifestationsinpatientswithcovid19pneumoniainveracruzmexico AT priegoparraedsonirving 345dermatologicalmanifestationsinpatientswithcovid19pneumoniainveracruzmexico AT reichsierrareynaldo 345dermatologicalmanifestationsinpatientswithcovid19pneumoniainveracruzmexico AT sanchezjimeneznoeljhosimar 345dermatologicalmanifestationsinpatientswithcovid19pneumoniainveracruzmexico AT tressucmariafernanda 345dermatologicalmanifestationsinpatientswithcovid19pneumoniainveracruzmexico AT velazquezorozcopaola 345dermatologicalmanifestationsinpatientswithcovid19pneumoniainveracruzmexico |